Filing Details

Accession Number:
0001209191-17-061052
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-16 08:54:14
Reporting Period:
2017-11-15
Accepted Time:
2017-11-16 08:54:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595097 Corbus Pharmaceuticals Holdings Inc. CRBP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292834 P David Hochman C/O Corbus Pharmaceuticals Holdings, Inc
100 River Ridge Drive
Norwood MA 02062
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-15 5,000 $6.55 220,000 No 4 P Indirect By NSH 2008 Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By NSH 2008 Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 459,500 Direct
Common Stock 4,300 Indirect By Solomon Asher Hochman Trust of 2005
Common Stock 4,300 Indirect By Hannah Hochman Trust of 2007
Common Stock 4,300 Indirect By Judah Herman Hochman Trust of 2009